Neuronetics (STIM) Cash from Operations (2017 - 2026)
Neuronetics' (STIM) quarterly Cash from Operations came in at -$1.0 million in Q2 2026, up 71.23% year-over-year from -$588672.0 in Q2 2025, and up 89.3% quarter-over-quarter from -$9.4 million in Q1 2026.
Analysis
Neuronetics (STIM) Cash from Operations (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Cash from Operations for 10 consecutive years, with -$1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 71.23% year-over-year to -$1.0 million in Q2 2026; TTM through Jun 2026 was -$10.3 million, a 70.06% increase from a year earlier, with the FY2025 full-year figure at -$20.4 million, up 34.19% from the prior year.
- Cash from Operations was -$1.0 million for Q2 2026 at Neuronetics, up from -$9.4 million in the prior quarter.
- Over five years, Cash from Operations peaked at $2.1 million in Q4 2023 and troughed at -$17.0 million in Q1 2025.
- A 5-year average of -$6.9 million and a median of -$7.6 million in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 168.81% in 2023 and slumped 503.14% in 2024, its largest moves.
- Over 5 years, Cash from Operations stood at -$3.1 million in 2022, then jumped by 168.81% to $2.1 million in 2023, then tumbled by 503.14% to -$8.6 million in 2024, then soared by 110.47% to $900000.0 in 2025, then tumbled by 212.0% to -$1.0 million in 2026.
- The last three Cash from Operations figures came in at -$1.0 million (Q2 2026), -$9.4 million (Q1 2026), and $900000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Neuronetics | 223.41 Mn | 203.98 Mn | 21.22 Mn | -1.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 Mn |
| Mar 31, 2026 | -9.42 Mn |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | -803,000.00 |
| Jun 30, 2025 | -3.50 Mn |
| Mar 31, 2025 | -16.99 Mn |
| Dec 31, 2024 | -8.60 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -4.97 Mn |
| Mar 31, 2024 | -12.02 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | -10.12 Mn |
| Jun 30, 2023 | -8.83 Mn |
| Mar 31, 2023 | -15.21 Mn |
| Dec 31, 2022 | -3.10 Mn |
| Sep 30, 2022 | -6.51 Mn |
| Jun 30, 2022 | -8.95 Mn |
| Mar 31, 2022 | -12.18 Mn |
| Dec 31, 2021 | -4.54 Mn |
| Sep 30, 2021 | -8.52 Mn |